Digitalis glycosides. Pharmacokinetics and their clinical implications.
D058186:Acute Kidney Injury / Q000150:complications; D000284:Administration, Oral; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy; D004074:Digitoxin / Q000097:blood / Q000378:metabolism* / Q000506:poisoning; D004077:Digoxin / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000506:poisoning / Q000652:urine; D004347:Drug Interactions; D004554:Electric Countershock; D006207:Half-Life; D006801:Humans; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D008107:Liver Diseases / Q000150:complications; D008286:Malabsorption Syndromes / Q000150:complications; D014677:Pharmaceutical Vehicles; D010672:Phenytoin / Q000627:therapeutic use; D011188:Potassium / Q000627:therapeutic use; D013959:Thyroid Diseases / Q000150:complications
D014677:Pharmaceutical Vehicles; D010672:Phenytoin; D004077:Digoxin; D004074:Digitoxin; D011188:Potassium